Pangu Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 23, 2021	Elixiron Immunotherapeutics	$27.0M Series A Extension	Pangu Capital	CDIB Capital Group, Daiwa Corporate Investment, Fubon Ventures, Hong Tai Electric Industrial, Mega International Commercial Bank
May 5, 2021	BridGene Biosciences	$12.0M Series A	Leilei Wang	Kaitai Capital, Takeda Ventures

Total Raised

N/A

Valuation

N/A